| abstract |
The present invention provides methods and compositions for use in the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease involving aberrant Ras superfamily signaling by binding of compounds to the GTP binding domain. of Ras superfamily proteins, including, in some cases, K-Ras and its mutants, the invention also relates to a novel method for assaying such compositions. |